SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-022610
Filing Date
2023-05-17
Accepted
2023-05-17 08:15:35
Documents
12
Period of Report
2023-05-17
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K rare-20230517.htm   iXBRL 8-K 48025
  Complete submission text file 0000950170-23-022610.txt   160660

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rare-20230517_pre.xml EX-101.PRE 9457
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rare-20230517_lab.xml EX-101.LAB 12806
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rare-20230517.xsd EX-101.SCH 2475
6 EXTRACTED XBRL INSTANCE DOCUMENT rare-20230517_htm.xml XML 4516
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36276 | Film No.: 23929687
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences